CVS Health (CVS)

Investing Cash Flow

-$6.84B

TTM · Period ending: · USD

CVS logo

CVS Investing Cash Flow

Latest reported-$6.84B
CVS TTM Cash from Investing (-$221.70M → -$6.84B)
High-resolution chart · PNG

CVS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

CVS Health Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-6,843,000,000
-5,983,000,000
-5,871,000,000
-4,420,000,000
-5,680,000,000
-6,281,000,000
-7,613,000,000
-8,308,000,000
-5,732,000,000
-14,469,000,000
-20,889,000,000
-19,766,000,000
-19,800,000,000
-11,568,000,000
-5,047,000,000
-6,368,000,000
-6,410,000,000
-5,387,000,000
-5,261,000,000
-5,055,000,000
-5,578,000,000
-5,804,000,000
-5,534,000,000
-5,009,000,000
-4,468,000,000
-4,045,000,000
-3,339,000,000
-44,529,000,000
-44,334,000,000
-44,045,000,000
-43,285,000,000
-2,710,000,000
-2,509,000,000
-2,485,000,000
-2,891,000,000
-2,385,000,000
-2,373,000,000
-2,374,000,000
-2,470,000,000
-4,072,000,000
-13,561,000,000
-13,509,000,000
-13,420,000,000
-11,511,000,000
-1,950,000,000
-2,029,000,000
-4,045,000,000
-3,747,000,000
-3,927,000,000
-3,828,000,000
-1,835,000,000
-2,288,000,000
-1,857,000,000
-1,973,000,000
-1,849,000,000
-1,030,000,000
-1,429,000,000
-2,554,000,000
-2,410,000,000
-2,815,000,000
-2,826,000,000
-1,542,000,000
-1,640,000,000
-1,411,700,000
-1,340,700,000
-1,020,700,000
-1,068,700,000
-4,352,500,000
-4,325,900,000
-4,678,800,000
-4,580,600,000
-1,303,100,000
-1,238,900,000
-1,164,700,000
-3,081,700,000
-2,341,900,000
-2,654,300,000
-6,562,700,000
-4,593,200,000
-5,306,000,000
-4,904,000,000
-890,000,000
-911,600,000
-986,700,000
-3,323,300,000
-3,267,900,000
-3,163,300,000
-3,153,900,000
-802,800,000
-744,300,000
-753,600,000
-793,900,000
-704,700,000
-702,600,000
-735,800,000
-673,000,000
-647,200,000
-589,400,000
-536,800,000
-539,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.